Literature DB >> 16889603

Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation.

T Goto1, T Yamashita, M Ueda, S Ohshima, K Yoneyama, M Nakamura, H Nanjo, K Asonuma, Y Inomata, S Watanabe, M Uchino, K Tanaka, Y Ando.   

Abstract

A 57-year-old woman in Japan, the first recipient of part of a liver from a 58-year-old man with familial amyloidotic polyneuropathy (FAP) amyloidogenic transthyretin Val30Met who had had sensorimotor polyneuropathy in the lower limbs for 3 years, started to develop sensory neuropathy 7 years after transplantation. Before the July 1998 sequential transplantation, she had been in a hepatic coma at the terminal stage of primary biliary cirrhosis and waiting for deceased donor liver transplantation. In September 2004, biopsy samples of her duodenum first showed amyloid deposition. Although biopsy materials in 2005 and 2006 showed no changes in amyloid deposition, decreased temperature sensation and pain in fingertips and toes were detected at a neurologic examination in March 2006. Thus, clinical symptoms of FAP appeared about 2 years after amyloid deposition started. Nerve conduction velocity studies revealed mild to moderate axonal sensory polyneuropathy without demyelination. Our findings confirmed iatrogenic sensory neuropathy induced by amyloid deposition 7 years after sequential liver transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16889603     DOI: 10.1111/j.1600-6143.2006.01484.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

Review 1.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 2.  Endoplasmic reticulum quality control and systemic amyloid disease: Impacting protein stability from the inside out.

Authors:  John J Chen; Joseph C Genereux; R Luke Wiseman
Journal:  IUBMB Life       Date:  2015-05-26       Impact factor: 3.885

Review 3.  Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.

Authors:  Shukuro Araki; Yukio Ando
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

4.  Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.

Authors:  Nina Norgren; Malin Olsson; Hanna Nyström; Bo Göran Ericzon; Marie de Tayrac; Emmanuelle Genin; Violaine Planté-Bordeneuve; Ole B Suhr
Journal:  Amyloid       Date:  2014-03-07       Impact factor: 7.141

Review 5.  Iatrogenic amyloid polyneuropathy after domino liver transplantation.

Authors:  Diana Mnatsakanova; Saša A Živković
Journal:  World J Hepatol       Date:  2017-01-28

6.  Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.

Authors:  Masaaki Matsushima; Ichiro Yabe; Masaya Tsuda; Mamoru Sakakibara; Tsuyoshi Shimamura; Hidenao Sasaki
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

Review 7.  Modulation of the Mechanisms Driving Transthyretin Amyloidosis.

Authors:  Filipa Bezerra; Maria João Saraiva; Maria Rosário Almeida
Journal:  Front Mol Neurosci       Date:  2020-12-11       Impact factor: 5.639

Review 8.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

9.  The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.

Authors:  Tsuneaki Yoshinaga; Masahide Yazaki; Yoshiki Sekijima; Fuyuki Kametani; Kana Miyashita; Naomi Hachiya; Tomohiro Tanaka; Norihiro Kokudo; Keiichi Higuchi; Shu-Ichi Ikeda
Journal:  J Pathol Clin Res       Date:  2016-01-21

Review 10.  Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2020-09-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.